The federal government has OK'd clinical trials of the outlawed drug ecstasy, known for its euphoric effects, as a means to treat post-traumatic stress disorder.
Commonly known as Molly or the chemical MDMA, the substance has been a popular club drug for decades.
In one previous trial, ecstasy was given to patients by the psychiatrist during therapy sessions as part of a larger treatment schedule. The patients, according to the New York Times, reported a 56 percent decrease in the severity of symptoms on average. By the end of the study, two-thirds of the patients no longer met the criteria for PTSD.